糖酸酶-1作为神经疾病治疗点
Harriet McHale-Owen1, Kiterie M E Faller2, Helena Chaytow1
1Biomedical Sciences, Edinburgh Medical School, University of Edinburgh, Edinburgh, UK; Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh, Edinburgh, UK.
Trends in molecular medicine
|April 15, 2025
概括
增加糖酸激酶1 (PGK1) 活性可能会改善像帕金森病这样的神经疾病的能量产生. 需要对PGK1激活剂进行进一步的研究,以释放其治疗潜力.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 代谢途径 代谢途径
背景情况:
- 糖酸酶1 (PGK1) 是糖解中的一个关键酶,对于ATP生产至关重要.
- 不调节的细胞代谢与各种神经系统疾病有关,包括帕金森病 (PD) 和运动神经元疾病 (MND).
研究的目的:
- 审查在神经疾病中增强PGK1活动的治疗潜力.
- 讨论开发PGK1向疗法的挑战和未来方向.
主要方法:
- 关于PGK1活性和神经疾病的最新证据的文献综述.
- 分析PGK1在细胞能量代谢中的作用.
- 检查当前的治疗策略和挑战.
主要成果:
- 有证据表明,增加PGK1活性可能对具有代谢失调的神经疾病有益.
- PGK1在细胞能量恒温中发挥着关键作用,影响神经元功能.
- 目前针对PGK1的治疗方法有限.
结论:
- 增强PGK1活动对神经系统疾病具有显著的治疗前景.
- 需要新的PGK1激活剂才能充分实现对患者的临床益处.
- 对PGK1聚焦疗法的进一步研究是有必要的.
相关概念视频
Protein Kinases and Phosphatases
12.9K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.9K
Enzyme-linked Receptors
76.3K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
76.3K
Parkinson's Disease: Overview
323
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
323
Phosphorylation
49.4K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
49.4K
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K


